TrialThe journals of gerontology. Series A, Biological sciences and medical sciences2019

Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older.

Desmond Curran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.